Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flumazenil vs saline after gynecological day surgery under remimazolam anesthesia
ChiCTR2300074137Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Aug 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative nausea and vomiting (PONV) and postoperative pain comparing Flumazenil 0.2 mg with Normal saline (placebo) (2 arms). Primary endpoint: Incidence of nausea and vomiting within 24 hours after surgery. Started Aug 2023; status: recruiting.
02
Drugs
flumazenil
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on ChiCTR2300074137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074137.